Rare Neurological Disease Treatment Industry Set to Skyrocket, Projected to Reach a US$ 19.795 Billion Horizon by 2032-FMI Report

The majority of rare diseases currently have no or few effective diagnostic and treatment procedures, which can be attributed in part to a lack of funding for research on rare disease pathogenesis and a lack of representative patients. rare neurological disease treatment industry are one of the most common types of rare diseases, with ineffective diagnoses …